| [1] |
Abt PL, Marsh CL, Dunn TB, et al. Challenges to research and innovation to optimize deceased donor organ quality and quantity[J]. Am J Transplant, 2013, 13(6):1400-1404. doi: 10.1111/ajt.12243
|
| [2] |
Dhanani S, Shemie SD. Advancing the science of organ donor management[J]. Crit Care, 2014, 18(6):612. doi: 10.1186/s13054-014-0612-z
|
| [3] |
Salim A, Martin M, Brown C, et al. Complications of brain death:frequency and impact on organ retrieval[J]. Am Surg, 2006, 72(5):377-381. https://www.ncbi.nlm.nih.gov/pubmed/16719188
|
| [4] |
Malinoski DJ, Patel MS, Daly MC, et al. The impact of meeting donor management goals on the number of organs transplanted per donor:results from the United Network for Organ Sharing Region 5 prospective donor management goals study[J]. Crit Care Med, 2012, 40(10):2773-2780. doi: 10.1097/CCM.0b013e31825b252a
|
| [5] |
Sally M, Malinoski D. Current research on organ donor management[J]. Anesthesiol Clin, 2013, 31(4):737-748. doi: 10.1016/j.anclin.2013.08.004
|
| [6] |
项和立, 薛武军, 田普训, 等.公民逝世后器官捐献供者的评估与维护[J].中华器官移植杂志, 2014, 35(7):392-395. http://www.docin.com/p-1104947575.html
|
| [7] |
Franklin GA, Santos AP, Smith JW, et al. Optimization of donor management goals yields increased organ use[J]. Am Surg, 2010, 76(6):587-594. https://www.ncbi.nlm.nih.gov/pubmed/20583513
|
| [8] |
Hagan ME, McClean D, Falcone CA, et al. Attaining specific donor management goals increases number of organs transplanted per donor:a quality improvement project[J]. Prog Transplant, 2009, 19(3):227-231. doi: 10.7182/prtr.19.3.wq3w28052k5q6334
|
| [9] |
Malinoski DJ, Daly MC, Patel MS, et al. Achieving donor management goals before deceased donor procurement is associated with more organs transplanted per donor[J]. J Trauma, 2011, 71(4):990-996. doi: 10.1097/TA.0b013e31822779e5
|
| [10] |
Hömme R, Neeser G. Organ donation[J]. Anaesthesist(德文), 2007, 56(12):1291-1303. doi: 10.1007/s00101-007-1284-8
|
| [11] |
Dupuis S, Amiel JA, Desgroseilliers M, et al. Corticosteroids in the management of brain-dead potential organ donors:a systematic review[J]. Br J Anaesth, 2014, 113(3):346-359. doi: 10.1093/bja/aeu154
|
| [12] |
Dictus C, Vienenkoetter B, Esmaeilzadeh M, et al. Critical care management of potential organ donors:our current standard[J]. Clin Transplant, 2009, 23(Suppl 21):2-9. https://www.ncbi.nlm.nih.gov/pubmed/19930309
|
| [13] |
Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies:effects on kidney function[J].Cochrane Database Syst Rev, 2013, 7:CD007594. https://www.ncbi.nlm.nih.gov/pubmed/23881659/
|
| [14] |
Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care[J]. N Engl J Med, 2012, 367(20):1901-1911. doi: 10.1056/NEJMoa1209759
|
| [15] |
Cittanova ML, Mavré J, Riou B, et al. Long-term follow-up of transplanted kidneys according to plasma volume expander of kidney donors[J]. Intensive Care Med, 2001, 27(11):1830. doi: 10.1007/s00134-001-1110-8
|
| [16] |
Venkateswaran RV, Patchell VB, Wilson IC, et al. Early donor management increases the retrieval rate of lungs for transplantation[J].Ann Thorac Surg, 2008, 85(1):278-286. doi: 10.1016/j.athoracsur.2007.07.092
|
| [17] |
Wood KE, Coursin DB. Intensivists and organ donor management[J]. Curr Opin Anaesthesiol, 2007, 20(2):97-99. doi: 10.1097/ACO.0b013e3280895ac8
|
| [18] |
Ishimura T, Muramaki M, Kishikawa H, et al. The impact of donor factors on early graft function in kidney transplantation from donation after cardiac death[J]. Transplant Proc, 2014, 46(4):1064-1066. doi: 10.1016/j.transproceed.2013.11.070
|
| [19] |
Marinosci GZ, De Robertis E, De Benedictis G, et al. Dopamine use in intensive care:are we ready to turn it down?[J]. Transl Med UniSa, 2012, 4:90-94. https://www.ncbi.nlm.nih.gov/pubmed/23905068
|
| [20] |
Cicci JD, Reed BN, McNeely EB, et al. Acute decompensated heart failure:evolving literature and implications for future practice[J]. Pharmacotherapy, 2014, 34(4):373-388. doi: 10.1002/phar.1369
|
| [21] |
García Sáez D, Zych B, Sabashnikov A, et al. Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile[J]. Ann Thorac Surg, 2014, 98(6):2099-2106. doi: 10.1016/j.athoracsur.2014.06.098
|
| [22] |
Spindler RS, Schnuelle P, Nickels L, et al. N-octanoyl dopamine for donor treatment in a brain-death model of kidney and heart transplantation[J]. Transplantation, 2015, 99(5):935-941. doi: 10.1097/TP.0000000000000577
|
| [23] |
Fontana J, Yard B, Stamellou E, et al. Dopamine treatment of brain-dead Fisher rats improves renal histology but not early renal function in Lewis recipients after prolonged static cold storage[J]. Transplant Proc, 2014, 46(10):3319-3325. doi: 10.1016/j.transproceed.2014.04.020
|
| [24] |
Hanusch C, Hauser C, Geisler A, et al. Reduction of oedema formation after preconditioning with dopamine in an isolated rat lung model is mediated by adrenergic receptors[J]. Ann Transplant, 2011, 16(3):97-107. doi: 10.12659/AOT.882001
|
| [25] |
Hanusch C, Nowak K, Törlitz P, et al. Donor dopamine treatment limits pulmonary oedema and inflammation in lung allografts subjected to prolonged hypothermia[J]. Transplantation, 2008, 85(10):1449-1455. doi: 10.1097/TP.0b013e31816f220d
|
| [26] |
Rech TH, Moraes RB, Crispim D, et al. Management of the brain-dead organ donor:a systematic review and meta-analysis[J]. Transplantation, 2013, 95(7):966-974. doi: 10.1097/TP.0b013e318283298e
|
| [27] |
Von Ziegler F, Helbig S, Kreissl N, et al. Norepinephrine versus dopamine pretreatment of potential heart donors-impact on long-term outcome[J]. Ann Transplant, 2013, 18:320-326. doi: 10.12659/AOT.883960
|
| [28] |
Callahan DS, Neville A, Bricker S, et al. The effect of arginine vasopressin on organ donor procurement and lung function[J]. J Surg Res, 2014, 186(1):452-457. doi: 10.1016/j.jss.2013.09.028
|
| [29] |
Stoica SC, Satchithananda DK, White PA, et al. Noradrenaline use in the human donor and relationship with load-independent right ventricular contractility[J]. Transplantation, 2004, 78(8):1193-1197. doi: 10.1097/01.TP.0000137792.74940.4F
|
| [30] |
Di Giantomasso D, Morimatsu H, Bellomo R, et al. Effect of low-dose vasopressin infusion on vital organ blood flow in the conscious normal and septic sheep[J]. Anaesth Intensive Care, 2006, 34(4):427-433.
|
| [31] |
Salim A, Martin M, Brown C, et al. Using thyroid hormone in brain-dead donors to maximize the number of organs available for transplantation[J]. Clin Transplant, 2007, 21(3):405-409. doi: 10.1111/ctr.2007.21.issue-3
|
| [32] |
冼颖欣, 陈国栋.心脏死亡器官捐献供肾质量评估和改善方法的新进展[J].器官移植, 2013, 4(2):113-116. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201302013.htm
Xian YX, Chen GD. New progress in assessment and improvement of graft quality in kidney transplantation from donation after cardiac death[J]. Organ Transplant, 2013, 4(2):113-116. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201302013.htm
|
| [33] |
Kotsch K, Ulrich F, Reutzel-Selke A, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation:a prospective randomized controlled trial[J]. Ann Surg, 2008, 248(6):1042-1050. doi: 10.1097/SLA.0b013e318190e70c
|
| [34] |
Hevesi ZG, Lopukhin SY, Angelini G, et al. Supportive care after brain death for the donor candidate[J]. Int Anesthesiol Clin, 2006, 44(3):21-34. doi: 10.1097/01.aia.0000210798.53007.4b
|
| [35] |
Kamiya M, Sato N, Nozaki A, et al. Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide[J]. J Cardiovasc Pharmacol, 2015, 65(3):282-288. doi: 10.1097/FJC.0000000000000193
|
| [36] |
Botha P, Rostron AJ, Fisher AJ, et al. Current strategies in donor selection and management[J]. Semin Thorac Cardiovasc Surg, 2008, 20(2):143-151. doi: 10.1053/j.semtcvs.2008.04.006
|
| [37] |
Ware LB, Landeck M, Koyama T, et al. A randomized trial of the effects of nebulized albuterol on pulmonary edema in brain-dead organ donors[J].Am J Transplant, 2014, 14(3):621-628. doi: 10.1111/ajt.12564
|
| [38] |
Angel LF, Levine DJ, Restrepo MI, et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes[J]. Am J Respir Crit Care Med, 2006, 174(6):710-716. doi: 10.1164/rccm.200603-432OC
|
| [39] |
Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation:a randomized controlled trial[J]. JAMA, 2010, 304(23):2620-2627. doi: 10.1001/jama.2010.1796
|
| [40] |
Hanna K, Seder CW, Weinberger JB, et al. Airway pressure release ventilation and successful lung donation[J]. Arch Surg, 2011, 146(3):325-328. doi: 10.1001/archsurg.2011.35
|
| [41] |
Peris A, Bagatti S, Lo Pane P, et al. Opposition to organ donation:prevention is better than applying tactics[J]. Crit Care, 2014, 18(6):598. doi: 10.1186/s13054-014-0598-6
|
| [42] |
胡益民, 纪木火.精氨酸加压素的临床应用[J].实用医学杂志, 2011, 27(13):2475-2477. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201113077.htm
Hu YM, Ji MH. Clinical application of arginine vasopressin[J]. J Pract Med, 2011, 27(13):2475-2477. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201113077.htm
|
| [43] |
Marshall GR, Mangus RS, Powelson JA, et al. Donor management parameters and organ yield:single center results[J]. J Surg Res, 2014, 191(1):208-213. doi: 10.1016/j.jss.2014.02.054
|
| [44] |
Shutter L. Pathophysiology of brain death:what does the brain do and what is lost in brain death?[J]. J Crit Care, 2014, 29(4):683-686. doi: 10.1016/j.jcrc.2014.04.016
|
| [45] |
Bernhardt AM, Reichenspurner H. High-risk donors:extending our criteria in times of organ shortage[J]. Curr Opin Organ Transplant, 2014, 19(5):494-499. doi: 10.1097/MOT.0000000000000118
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: